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Abamectin is a drug with antiparasitic properties used in several pharmaceutical formulations. The 
objective of this research was to develop and validate a high performance liquid chromatographic (HPLC) 
method for quantification of the two abamectin homologs (H2B1a and H2B1b) in gel formulation. This 
HPLC method was validated using a LichroCart® 100 RP-18 (125 x 4 mm, 5 µm) column. The mobile 
phase contained of acetonitrile and water (95:5 v/v) with 1% acetic acid. The flow rate was 1.0 mL min-1 
and UV detection was performed at 245 nm. Mobile phase solutions were prepared containing a nominal 
concentration 185.2 µg mL-1 H2B1a and 9.6 µg mL-1 H2B1b. The method displayed good linearity in the 
concentration range of 148.1 – 222.3 µg mL-1 and 7.7 – 11.5 µg mL-1, for H2B1a and H2B1b, respectively, 
with a correlation coefficient of (r)> 0.99 for both compounds, calculated by the least mean squares method. 
Detection limits (DLs) were 2.8 µg mL-1 and 1.2 µg mL-1 and quantitation limits (QLs) were 8.6 µg mL-1 
and 3.8 µg mL-1, for H2B1a and H2B1b, respectively. The method is simple, economical and efficient for 
the quantitative determination of abamectin H2B1a and H2B1b homologs in pharmaceutical preparations.
Uniterms: Abamectin homologs/validation method/gel formulation. Abamectin homologs. High 
Perfomance Liquid Chromatography (HPLC).
INTRODUCTION
Avermectins are a group of fermentation products 
obtained from a strain of Streptomyces avermitilis and 
are 16-membered macrocyclic lactones, and comprise 
several derivatives including abamectin (Xie et al., 2011). 
Abamectin (Figure 1) is used in veterinary practice as 
an antiparasitic and in agriculture as an insecticide. 
Abamectin consists of a mixture of two homologous 
compounds: H2B1a (at least 80%) and avermectin H2B1b 
(no more than 20%) (Shoop, Mrozik, Fisher, 1995). 
Metabolic studies, have shown that abamectin H2B1b 
is generally metabolized more rapidly than the H2B1a 
homolog and therefore, H2B1a is the major residue found 
in tissues and biological fluids (Markus, Sherma, 1992). 
Abamectin was suspected causing adverse effects in the 
aquatic environment, even in low concentrations, as 
it presents high toxicity to aquatic organisms, such as 
fish and microcrustaceans (Tisler, Erzen, 2006). Several 
different methods have been reported in scientific literature 
for the analyses of abamectin, such as, high performance 
liquid chromatography (HPLC) (Kulik et al., 2011), 
liquid chromatography coupled to mass spectrometry 
(LC-MS) (Valenzuela et al., 2000; Pozo et al., 2003; 
Yoshii et al., 2004; Xiaolin et al., 2006; Thompson et al., 
2009; Rübensam et al., 2011; Tao et al., 2012; Campillo 
et al., 2013; Ismail et al., 2013), HPLC with fluorescence 
(Diserens, Henzelin,1999; Souza et al., 2003; Kolar et al., 
2004; Borges et al., 2008; Cerkvenik-Flajsa et al., 2010; 
Xie et al., 2011; Rahman et al., 2013), and UHPLC with 
fluorescence (Liu et al., 2001; Romero-González et al., 
2011). The aim of this research was to validate a HPLC 
method for quantitative determination of abamectin 
homologs (H2B1a and H2B1b) in gel formulation, as this 
drug is widely used in veterinary practice. Abamectin 
consists of a mixture of two homologous compounds: 
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H2B1a (at least 80%) and avermectin H2B1b (Shoop, Mrozik, 
Fisher, 1995). It is very important to separate and quantify 
both simultaneously since each homolog in abamectin has a 
specific concentration. The proposed method was developed 
and validated proposed to enable the separation and 
quantitative determination of the two abamectin homologs, 
in a short period of time; using a simple mobile phase in the 
chromatographic runs. The principal justification for this 
research was that there were very few methods described 
in literature for simultaneous quantitative determination 
of abamectin homologs, H2B1a and H2B1b. The proposed 
method presented a shorter analysis period compared to 
those described in literature, which is an advantage in 
quality control. It is a precise, and accurate method with 
can be used in routine analysis for quality control of gel 
formulation containing H2B1a and H2B1b. 
MATERIAL AND METHODS
Chemicals and reagents
A mixture (98.7% purity) of abamectin H2B1a 
(93.8%) and H2B1b (4.9%) was donated by a pharmaceutical 
company. The gel formulation was a commercially 
available preparation containing 1% abamectin/ 10 g. 
Placebo was prepared in the laboratory containing the 
following excipients: hydroxyethylcellulose (1.00 g), 
EDTA (0.10 g), methyl paraben (0.20 g) and propyl 
paraben (0.10 g), imidazolinidyl urea solution 50% (0.60 
g) and distilled water q.s.p 100.00 g.
The chromatographic grade methanol  and 
acetonitrile were purchased from J. T. Baker® (Philipsburg, 
USA). Acetic acid was purchased from Vetec® (Rio de 
Janeiro, Brazil). Ultrapure water was obtained by using 
a Milli-Q® water purification system (Millipore® Co., 
Milford, MA, USA).
The mobile phase consisted of acetonitrile and water 
(95:5 v/v) with 1% acetic acid. The flow rate was 1.0 mL 
min-1 and UV detection was made at 245 nm. Solutions 
were prepared in the mobile phase containing 185.2 µg 
mL-1 H2B1a and 9.6 µg mL-1 of H2B1b.
Instrumentation
The proposed HPLC quantitative method was 
developed using the following equipment a solvent-delivery 
system, an auto-injector fitted with a 20 µL loop, an online 
degasification system, a column thermostat oven and an 
ultraviolet/visible (UV/VIS) with photodiode array detector. 
The output signal was monitored and integrated using Class-
VP® 5.03 software (Shimadzu® Corporation, Kyoto, Japan). 
The mobile phase was filtered through a 0.45 µm PTFE 
Millipore® membrane (Millipore, Milford, USA). A Mettler 
AL204 analytical balance was used to weigh all compounds.
Procedures
Method validation
The method was validated according to the United 
States Pharmacopeia, 37th ed. (USP, 2014) and International 
Conference on Harmonization Guidelines (ICH, 2005).
Analytical curves
Analytical curves for abamectin were obtained using 
five different concentration levels, in each of the following 
ranges: 148.1 - 222.3 µg mL-1 and 7.7 - 11.5 µg mL-1, for 
H2B1a and H2B1b, respectively. Standard solutions were 
diluted with mobile phase and determinations were made 
in triplicate.
System suitability
Standard solutions containing 185.2 µg mL-1 H2B1a 
and 9.6 µg mL-1 H2B1b abamectin were prepared by dilution 
in the mobile phase. System suitability was determined 
from ten replicate injections of each standard solution.
Precision
Precision was obtained by determining the 
repeatability and intermediate precision. Repeatability was 
tested by analyzing six replicates of sample a concentration 
of 185.2 µg mL-1 H2B1a and 9.6 µg mL-1 H2B1b. Intermediate 
precision was obtained by performing the analysis, in 
triplicate on two different days using different analysts, 
using sample solutions in a concentration of 185.2 µg 
mL-1 H2B1a and 9.6 µg mL-1 H2B1b. Solutions were filtered 
FIGURE 1 - Chemical structures the abamectin homologs (H2B1a 
and H2B1b) (Xie et al., 2011).
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through a 0.45 µm Millipore® (PTFE) membrane before 
injection into the HPLC system.
Accuracy
Accuracy was assessed by determining the 
agreement between measured analyte concentrations of 
fortified and unfortified sample when a known amount of 
standard was added to the sample.
A quantity of 25.0 mg of abamectin standard 
(H2B1a and H2B1b) was weighed and transferred to a 25 
mL volumetric flask. After addition of 20 mL mobile 
phase, the solution was sonicated for 5 min. The volume 
was completed with the same solvent (solution A). Final 
concentration was 1000.0 µg mL-1. Aliquots of 0.8, 1.0 and 
1.2 mL were transferred to 5 mL volumetric flasks. The 
volumes were completed with mobile phase.
An amount equivalent to 25.0 mg of the placebo 
gel formulation was weighed and transferred to a 25 mL 
volumetric flask. After addition of 20 mL of mobile phase, 
the solution was sonicated for 5 min. The volume was 
completed with the same solvent (solution B). Aliquots 
of 1.0 mL were transferred to 5 mL volumetric flasks. The 
volumes were completed with mobile phase.
As described in RE 899 placebo solutions were 
fortified by transferring 1.0 mL of sample solution (solution 
B) to 5 mL volumetric flasks, followed by addition of 0.8, 
1.0 and 1.2 mL of standard solution (solution A). The 
volumes were completed with ultrapure water. Solutions 
were filtered through a 0.45 µm Millipore® (PTFE) 
membrane before injection into the HPLC system.
Stability test
Standard and sample solutions were prepared 
separately, as previously described, to obtain solutions 
containing 185.2 µg mL-1 of H2B1a and 9.6 µg mL-1 of 
H2B1b. These solutions were stored at 25°C and triplicate 
measurements were made during a period of 4 hours.
Robustness test
The UV detection wavelength and mobile phase 
composition were deliberately modified. Mobile phases 
consisted of acetonitrile and water (96:4 v/v) with 1% 
acetic acid and acetonitrile and water (94:6 v/v) with 1% 
acetic acid. UV detection was performed at 243 and 247 
nm. The standard and sample solutions containing 185.2 
µg mL-1 H2B1a and 9.6 µg mL-1 H2B1b were prepared by 
dilution in ultrapure water and injected in triplicate.
Stress testing
Stress testing was made as per Klick et al., 2005. 
Evaluation was performed in neutral hydrolysis, acid 
hydrolysis, alkaline hydrolysis and chemical oxidations.
Standard solution was prepared by transferring 
25.0 mg of abamectin to a 25 mL volumetric flask. 
Sample solution was prepared by transferring 2500.0 
mg of the gel formulation (equivalent to 25.0 mg of 
abamectin) to a 25 mL volumetric flask. To the standard 
and sample solutions, 20 mL of mobile phase were 
added and solutions sonicated for 5 min. Volume were 
completed with the same solvent. Aliquots of 1.0 mL 
of both solutions were transferred to 5 mL volumetric 
flasks. Neutral hydrolysis was performed by adding 1.0 
mL of water, chemical oxidations were performed by 
adding 1.0 mL of 3% H2O2 solution, acid hydrolysis was 
performed by adding 1.0 mL of 1 mol L-1 HCl solution 
and alkaline hydrolysis was performed by adding 1.0 mL 
of 1 mol L-1 NaOH solution. After cooling the volumes 
were completed with mobile phase. The solutions were 
heated to 80 ºC for 2 hours. The proposed method was 
used to analyze sample solutions in a concentration of 
185.2 µg mL-1 H2B1a and 9.6 µg mL-1 H2B1b. Mobile 
phase was filtered through a 0.45 µm PTFE Millipore® 
membrane (Millipore, Milford, USA).
RESULTS AND DISCUSSION
Ideal conditions for obtaining a good separation of 
abamectin homologs (H2B1a and H2B1b) were achieved 
using a mobile phase consisting of acetonitrile and water 
(95:5 v/v) with 1% acetic acid. It was observed that pH 
adjustment was not required because the final pH of the 
mobile phase (4.47) was favorable for use considering 
abamectin pka (Figure 2). Mean retention times (RT) for 
H2B1a and H2B1b were, 2.6 and 2.3 min, respectively. The 
resulting chromatograms can be observed in Figure 4.
Linearity
From analytical data, the responses obtained 
FIGURE 2 - Abamectin pkas observed in different pHs 
(Chemicalize, 2016).
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for the two homologs were linear in the concentration 
ranges from: 148.1– 222.3 µg mL-1 and 7.7 – 11.5 µg 
mL-1, for H2B1a and H2B1b, respectively. These ranges 
were used based on ICH (ICH, 2005) which indicates 
a range from 80 to 120% of the test concentration for 
the assay of a drug substance or a finished drug product. 
Correlation coefficients were 0.9961 for H2B1a and 0.9960 
for H2B1b. The F Test was also performed which confirm 
the proportionality of linear regression, resulting from 
analysis of variance. The experimental value must be 
greater than the default value for a confidence level of 
95 % (Pimentel, Barros Neto, 1996). The value obtained 
was 10 times larger than the standard value (6.39) 
(Table I). 
As important as the F test is residual analysis 
(Figure 3), which demonstrates an optimal distribution of 
the results (Pimentel, Barros Neto, 1995).
System suitability
Standard solutions were injected, and relative 
standard deviations (RSD) for each parameter were 
determined. In all cases, RSD values were less than 2%, 
which proves the reliability of the proposed analytical 
method (Table II).
Precision
Precision was obtained by determining repeatability 
and intermediate precision. The repeatability was 
conducted by analyzing six replicates of the sample 
at the concentration of 85.2 µg mL-1 H2B1a and 9.6 µg 
mL-1 H2B1b. Relative standard deviation (RSD) was 
determined. Intermediate precision was obtained by 
analyzing triplicates of the sample in the concentration 
of 185.2 µg mL-1 H2B1a and 9.6 µg mL-1 H2B1b. The RSD 
was determined after triplicate analysis of samples on two 
TABLE I - Linear regression data obtained in the analyses of abamectin homologs H2B1a and H2B1b using the proposed HPLC method
Statistical parameters H2B1a H2B1b
Concentration range* (µg mL1) 148.1– 222.3 7.7 – 11.5
Regression equation y= 32305x + 1x106 y= 15475x+133889
Correlation coefficient 0.9961 0.9960
Detection limit (µg mL-1) 2.8 1.2
Quantitation limit (µg mL-1) 8.6 3.8
F test * * 379.50 371.01
* n= 5; * * value of 95%, 6.39.
FIGURE 3 - Residual analysis of abamectin (H2B1a and H2B1b).
TABLE II - System suitability test results using final concentration 
of the sample solution: 185.2 µg mL-1 H2B1a and 9.6 µg mL-1 
H2B1b 
Parameters H2B1a* H2B1b*
Retention time 2.61± 0.38 2.28± 0.26
Area 6602238± 0.80 465191± 0.65
Peak height 854701± 0.84 24642± 0.68
Theoretical plates 4646± 0.48 4692± 0.51
Capacity factor 1.44± 0.45 1.13± 0.50
Assimetry 1.25± 0.00 1.33± 0.00
* Average of 10 determinations
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different days using two different analysts. The method 
presented good results for precision (Table III).
Accuracy
Recovery was evaluated by adding known amounts 
of abamectin H2B1a and H2B1b standard solutions to the 
abamectin gel sample. Recovery was evaluated at three 
different concentration levels. Triplicate determinations 
were performed at each concentration. Average recoveries 
of 98.62% ± 0.23 for H2B1a and 100.06% ± 0.95 for 
H2B1b, at three different concentration levels were 
obtained, indicating good accuracy for the proposed 
chromatographic method (Table IV).
Specificity
The placebo solution was prepared and analyzed 
using the proposed HPLC method. Results were compared 
with those obtained in the analyses of standard and 
sample. The excipients did not interfere in the method. 
The method was considered specific for the simultaneous 
determination of abamectin homologs H2B1a and H2B1b in 
gel formulation (Figure 4).
Detection limit (DL) and quantitation limit (QL)
The DL and QL were determined based on the 
standard deviation between response and slope of the 
curve. The theoretically obtained values for QL were 
cross-checked by performing analyses using the proposed 
HPLC method. DLs were 2.8 µg mL-1 and 1.2 µg mL-1, 
and QLs were 8.6 µg mL-1 and 3.8 µg mL-1, for H2B1a and 
H2B1b, respectively (Table I).
Stability of solutions
It is essential to evaluate the stability of standard and 
sample solutions to obtain reliable results. Standard and 
sample solutions were stored at 25 °C for 4 hours and after 
analyses the obtained results were compared with those 
obtained using freshly prepared solutions. No differences 
were observed in the instrumental responses under the 
described conditions. The RSDs obtained in the stability 
test were 1.19% and 0.44%, respectively for H2B1a and 
H2B1b (Table V), which were similar to those obtained 
using freshly prepared solutions.
Robustness
Deliberate changes in analytical parameters, did not 
lead to significant changes in the instrumental responses, 
and RSDs values were less than 2% in all cases. When the 
TABLE III - Precision analysis results obtained for the proposed 
HPLC method for determining abamectin homologs H2B1a and 
H2B1b in gel formulation
Precision H2B1a(%) H2B1b (%)
Repeatability a 92.29 ± 0.65 6.37 ± 0.06
RSD (%) 0.88 1.16
Intermediate precision b 92.07± 0.01 6.43 ± 0.03
93.52± 0.01 6.57 ± 0.08
Mean value 92.80 6.50
RSD (%) 1.10 1.52
a arithmetic mean value (n = 6); b arithmetic mean value (n = 2)
TABLE IV - Recovery results for abamectin H2B1a and H2B1b 
homolog standard solutions added to sample and analyzed by 
the proposed HPLC method
Compound Added amount (µg mL-1)
Found amount 
(µg mL-1)
Recovery 
( %)
H2B1a
150.62 
187.53 
225.13
148.15 ± 0.77 
185.26 ± 0.01 
222.27 ± 1.04
98.36 
98.79 
98.72
H2B1b
7.70 
9.57 
11.64
7.70 ± 0.07 
9.67 ± 0.01 
11.54 ± 0.01
100.00 
101.04 
99.14
FIGURE 4 - Chromatograms of placebo, standard, sample 
and mobile phase solutions. Chromatographic conditions: 
concentrations: 185.2 µg mL-1 for H2B1a and 9.6 µg mL-1 for 
H2B1b, column: LichroCart® 100 RP-18 (125 x 4 mm, 5 µm), 
mobile phase: acetonitrile and water (95:5 v/v) with 1% acetic 
acid, flow rate: 1.0 mL min-1, UV detection, at 245 nm and 
temperature, 25 ± 1 °C.
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wavelength was changed to 243 nm, the obtained RSDs 
were 0.86% and 0.99% and when changed to 247 nm, 
were 0.47% and 1.74% for H2B1a and H2B1b, respectively. 
When mobile phase composition was changed to 96:4 v/v 
acetonitrile and water with 1% acetic acid, RSDs were 
0.10% and 0.44% for H2B1a and H2B1b, respectively. When 
changed to 94:6 v/v acetonitrile and water with 1% acetic 
acid, RSDs were 0.62% and 0.88% for H2B1a and H2B1b, 
respectively. All results obtained in the robustness test 
were similar to those under initial conditions. Thus, the 
proposed method can be considered reliable and robust.
Stress testing
Stress testing studies are used to assess drug 
substance and drug product stability to provide information 
on possible degradation pathways, and to demonstrate the 
stability-indicating capability of the analysis methods used. 
These studies are performed under more drastic conditions 
than those used for accelerated stability tests (Klick et al., 
2005). Stress testing was conducted using neutral, acid 
and alkaline hydrolysis and chemical oxidation. After 
chemical oxidation and neutral hydrolysis, the results 
showed no significant changes in peak degradation, 
however, a different retention time was observed for the 
H2B1a standard substance. After both acid and alkaline 
hydrolysis, degradation was observed in both standard 
and sample substances (Figure 4).
The proposed method was appropriate for 
determining of abamectin homologs, H2B1a and H2B1b 
, in the presence of their degradation products, since 
all compounds could be separated, as seen in the 
chromatograms. Thus, the proposed HPLC method can be 
used in quality control as a stability- indicating method.
CONCLUSION
There are few methods described in literature for 
simultaneous quantitative determination of abamectin 
homologs H2B1a and H2B1b. Most methods described in 
literature just quantify total abamectin fraction.
The proposed HPLC method is simple, economic and 
TABLE V - Results from the stability test for abamectin H2B1a 
and H2B1b
Condition/RSD H2B1a(%)a H2B1b (%)a
Initial conditions 92.07± 0.01 6.43 ± 0.03
After stability test 93.63± 0.01 6.39 ± 0.01
RSD (%) 1.19 0.44
a n= 3
FIGURE 5 - Representative chromatograms standard reference homologs and sample solutions after stress testing. Concentration: 
185.2 µg mL-1 H2B1a and 9.6 µg H2B1b. Chromatograms: initial condition (A), neutral hydrolysis (B), chemical oxidation (C), acid 
hydrolysis (D), and alkaline hydrolysis (E). Chromatographic conditions: same as described in Figure 2
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efficient for the separation and quantitative determination 
of the two homologs in gel formulation, and can thus 
be considered an important tool in quality control. The 
advantage of the proposed method over those described 
in scientific literature is the speed, leading to economy of 
solvents. It is very important to quantify these homologs 
as abamectin was identified as probable cause of adverse 
effects in the aquatic environment, even when present in 
low concentrations (Cerkvenik-Flajsa et al., 2010). The 
excipients did not interfere in the analyses proving that 
the method presents selectivity. The proposed HPLC 
method proved to be useful and reliable and can be used to 
indicate the stability of routine analyses in quality control 
laboratories.
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